| |
FDA Approval Activities for this Drug
Cefadroxil Capsules USP, 500 mg (base) Barr ANDA 65-015 6/22/99 6/22/99
Cefadroxil for Suspension USP Powder, 125 mg/5 mL, 250 mg/5 mL, and 500 mg/5 mL, Ranbaxy ANDA 65-115 3/26/03
Cefadroxil Tablets USP, 1 g base Ranbaxy ANDA 65-018 Duricef® (cefadroxil monohydrate, USP) Capsules, Suspension & Tablets, Bristol-Myers Squibb Company NDA 50-512/S-044, 50-527/S-020 & 50-528/S-018 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE CEFADROXIL APOTHECON
065015 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE CEFADROXIL Barr 062766 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE CEFADROXIL Ivax 050512 CEFADROXIL/CEFADROXIL HEMIHYDRATE Capsule; 500MG BASE DURICEF WARNER CHILCOTT
065115 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 125MG BASE/5ML CEFADROXIL Ranbaxy
065115 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 250MG BASE/5ML CEFADROXIL Ranbaxy
065115 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 500MG BASE/5ML CEFADROXIL Ranbaxy
050527 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 125MG BASE/5ML DURICEF WARNER CHILCOTT
050527 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 250MG BASE/5ML DURICEF WARNER CHILCOTT
050527 CEFADROXIL/CEFADROXIL HEMIHYDRATE For Suspension; 500MG BASE/5ML DURICEF WARNER CHILCOTT
065018 CEFADROXIL/CEFADROXIL HEMIHYDRATE Tablet; 1GM BASE CEFADROXIL Ranbaxy
050528 CEFADROXIL/CEFADROXIL HEMIHYDRATE Tablet; 1GM BASE DURICEF WARNER CHILCOTT Duricef (cefadroxil monohydrate, USP) Capsules, Oral Suspension & Tablets, Bristol-Myers Squibb Company
For the latest approval information, please see the main page.
|